RecruitingNCT06926959
Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)
Sponsor
Sun Yat-sen University
Enrollment
3,000 participants
Start Date
Jun 15, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a multicenter cohort study including patients diagnosed with tricuspid regurgitation during hospitalization. The primary outcome of the study is all-cause death, and the secondary outcome is cardiovascular events. The prognostic risk factors of patients with tricuspid regurgitation are evaluated, and the prognostic models are constructed through the follow-up observation.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Aged over 18 yrs.
- Patients diagnosed with tricuspid regurgitation during hospitalization.
Exclusion Criteria1
- Patients unable to provide informed consent.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06926959
Related Trials
Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.
NCT074641061 location
The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent Events Evaluation
NCT070856501 location
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
NCT0613780736 locations
ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation
NCT068386111 location
Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
NCT0511485028 locations